577 results on '"Copolov, David"'
Search Results
2. Discontinuing antipsychotic therapy
3. Binding of SEP-363856 within TAAR1 and the 5HT1A receptor: implications for the design of novel antipsychotic drugs
4. Seven decades of antipsychotic drugs: Why is the life of Australians with schizophrenia still so suboptimal?
5. Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia
6. Seven decades of antipsychotic drugs: Why is the life of Australians with schizophrenia still so suboptimal?
7. What clinicians need to know about intranasal esketamine for treatment-resistant depression?
8. Association between long-term use of prolactin-elevating antipsychotics in women and the risk of breast cancer: What are the clinical implications?
9. Understanding the pathophysiology of schizophrenia: Contributions from the Melbourne Psychiatric Brain Bank
10. Interhemispheric EEG coherence is reduced in auditory cortical regions in schizophrenia patients with auditory hallucinations
11. Acceptance and commitment therapy for psychosis: randomised controlled trial
12. Interhemispheric transfer time in patients with auditory hallucinations: An auditory event-related potential study
13. A randomised controlled trial of acceptance-based cognitive behavioural therapy for command hallucinations in psychotic disorders
14. Real-world performance of Victorian hospitals during the COVID-19 lockdowns
15. Endocrine disturbances in affective disorders and schizophrenia : a selected review of the literature
16. Competence to Give Informed Consent to Research Participation in Persons with Schizophrenia and Related Psychosis
17. Command Hallucinations and Violence: Implications for Detention and Treatment
18. Diagnostic and symptomatological assessment
19. Response to Myles et al.: Changing the policy narrative on psychiatric inpatient care
20. No Correlation between A(–1438)G Polymorphism in 5-HT2A Receptor Gene Promoter and the Density of Frontal Cortical 5-HT2A Receptors in Schizophrenia
21. Binding of SEP-363856 within TAAR1 and the 5HT1A receptor: implications for the design of novel antipsychotic drugs
22. Re-balancing Victorian psychiatric services: Will increasing the supply of community services impact upon hospital demand?
23. The Butterfly Effect: Poor access to non-acute psychiatric beds and the emergency department congestion crisis in WA
24. Aspects of the measurement, physiology and pathophysiology of immunoreactive beta-endorphin
25. A New Phenomenological Survey of Auditory Hallucinations: Evidence for Subtypes and Implications for Theory and Practice
26. Corrigendum to ‘Have we overlooked the significance of multinodal hallucinations in schizophrenia?’ [Psychiatry Research 279 (2019) 358–360]
27. Antipsychotic treatment in clinical high risk for psychosis: Iatrogenesis related to dopamine supersensitivity psychosis?
28. The Voices Acceptance and Action Scale (VAAS) pilot data
29. Australia's National Mental Health Service Planning Framework: Are opinion-based algorithms driving mental health policy?
30. Olfactory sensitivity through the course of psychosis: Relationships to olfactory identification, symptomatology and the schizophrenia odour
31. Clozapine decreases [3H] CP 55940 binding to the cannabinoid1 receptor in the rat nucleus accumbens
32. Responses to the opinion-based algorithms driving the National Mental Health Service Planning Framework
33. The management of negative symptoms
34. Postmortem studies of the brain cannabinoid system in schizophrenia
35. Effects of N-acetyl cysteine on cognitive function in bipolar disorder
36. Have we overlooked the significance of multinodal hallucinations in schizophrenia?
37. Whoʼs left? Symptoms of schizophrenia that predict clinical trial dropout
38. Dimensions of improvement in a clinical trial of N-acetyl cysteine for bipolar disorder
39. Jumping off the bandwagon: Does the Basaglian de-hospitalised model work outside Trieste?
40. Australia’s National Mental Health Service Planning Framework: Are opinion-based algorithms driving mental health policy?
41. Interaction of glutathione depletion and psychotropic drug treatment in prepulse inhibition in rats and mice
42. No Association between the Serotonin Transporter-Linked Promoter Region Polymorphism and Either Schizophrenia or Density of the Serotonin Transporter in Human Hippocampus
43. Decreased serotonin2A receptors in Brodmann’s area 9 from schizophrenic subjects: A pathological or pharmacological phenomenon?
44. Effects of N-acetylcysteine on substance use in bipolar disorder: A randomised placebo-controlled clinical trial
45. Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice
46. EEG coherence measures during auditory hallucinations in schizophrenia
47. Re-balancing Victorian psychiatric services: Will increasing the supply of community services impact upon hospital demand?
48. The endogenous cannabinoid system in schizophrenia
49. Discontinuing Antipsychotic Therapy: A Practical Guide
50. Diseases of white matter and schizophrenia-like psychosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.